BKA
TMO icon

Brick & Kyle Associates’s Thermo Fisher Scientific TMO Stock Holding History

Brick & Kyle Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62M Sell
9,398
-707
-7% -$384K 1.52% 22
2025
Q4 		$5.86M Sell
10,105
-4
-0% -$2.26K 2.08% 17
2025
Q3 		$4.9M Sell
10,109
-20
-0.2% -$9.31K 1.81% 23
2025
Q2 		$4.27M Buy
10,129
+261
+3% +$109K 1.89% 21
2025
Q1 		$4.83M Buy
9,868
+30
+0.3% +$16.2K 2.22% 17
2024
Q4 		$5.12M Buy
9,838
+783
+9% +$430K 2.18% 16
2024
Q3 		$5.57M Sell
9,055
-182
-2% -$108K 2.39% 15
2024
Q2 		$5.11M Sell
9,237
-60
-0.6% -$34.4K 2.11% 17
2024
Q1 		$5.36M Sell
9,297
-124
-1% -$69.6K 2.37% 14
2023
Q4 		$5M Sell
9,421
-9
-0.1% -$4.36K 2.49% 15
2023
Q3 		$4.77M Buy
9,430
+51
+0.5% +$27.2K 2.53% 13
2023
Q2 		$4.88M Buy
9,379
+428
+5% +$231K 2.61% 16
2023
Q1 		$5.16M Sell
8,951
-6
-0.1% -$3.38K 2.96% 12
2022
Q4 		$4.93M Sell
8,957
-83
-0.9% -$44K 2.87% 10
2022
Q3 		$4.61M Sell
9,040
-26
-0.3% -$14.6K 2.8% 11
2022
Q2 		$4.9M Sell
9,066
-48
-0.5% -$26.4K 2.75% 12
2022
Q1 		$5.38M Sell
9,114
-9,120
-50% -$5.24M 2.61% 12
2021
Q4 		$12.2M Buy
18,234
+9,146
+101% +$5.71M 2.83% 9
2021
Q3 		$5.26M Buy
9,088
+175
+2% +$96K 2.67% 12
2021
Q2 		$4.5M Sell
8,913
-32
-0.4% -$15.1K 2.35% 18
2021
Q1 		$4.1M Buy
+8,945
New +$4.27M 2.26% 21
2017
Q2 		– Sell
-16
Closed -$2K – 329
2017
Q1 		$2K Hold
16
– – ﹤0.01% 402
2016
Q4 		$2K Hold
16
– – ﹤0.01% 414
2016
Q3 		$3K Buy
+16
New +$2.47K ﹤0.01% 406

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brick & Kyle Associates's TMO Position: Q1 2026 in Review

Brick & Kyle Associates reduced its Thermo Fisher Scientific (TMO) stake by 7% in Q1 2026, selling an estimated $384K and leaving 9,398 shares worth $4.62M. The position accounts for 1.52% of the portfolio, ranked #22.

Brick & Kyle Associates first reported a position in TMO in Q3 2016 and has held it in 24 quarters since. The position peaked at $12.2M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Brick & Kyle Associates held 9,398 shares of Thermo Fisher Scientific worth $4.62M as of Q1 2026.
  • Brick & Kyle Associates sold 707 Thermo Fisher Scientific shares in Q1 2026, an estimated $384K.
  • Thermo Fisher Scientific made up 1.52% of Brick & Kyle Associates's portfolio in Q1 2026, its #22 holding.
  • Brick & Kyle Associates first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 24 quarters since.
  • Brick & Kyle Associates's Thermo Fisher Scientific position peaked at $12.2M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brick & Kyle Associates's 13F filing for Q1 2026, filed 2 Jul 2026.